Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jan;12(1):15-26.
doi: 10.1007/s13346-021-00898-6. Epub 2021 Jan 23.

Influencing factors and drug application of iontophoresis in transdermal drug delivery: an overview of recent progress

Affiliations
Review

Influencing factors and drug application of iontophoresis in transdermal drug delivery: an overview of recent progress

Yu Wang et al. Drug Deliv Transl Res. 2022 Jan.

Abstract

Transdermal drug delivery is limited by the stratum corneum of skin, which blocks most molecules, and thus, only few molecules with specific physicochemical properties (molecular weight < 500 Da, adequate lipophilicity, and low melting point) are able to penetrate the skin. Recently, various technologies have been developed to overcome the strong barrier properties of stratum corneum. Iontophoresis technology, which uses a small current to improve drug permeation through skin, is one of the effective ways to circumvent the stratum corneum. This approach not only provides a more efficient, noninvasive, and patient-friendly method of drug delivery but also widens the scope of drugs for transdermal delivery. In this review, the mechanisms underlying iontophoresis and affecting factors are outlined. The focus will be on the latest advancements in iontophoretic transdermal drug delivery and application of iontophoresis with other enhancing technologies. The challenges of this technology for drug administration have also been highlighted, and some iontophoretic systems approved for clinical use are described.

Keywords: Combination; Drug delivery; Electric current; Iontophoresis; Transdermal.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Pastore MN, Kalia YN, Horstmann M, Roberts MS. Transdermal patches: history, development and pharmacology. Br J Pharmacol. 2015;172(9):2179–209. - PubMed - PMC - DOI
    1. Lane ME. Skin penetration enhancers. Int J Pharm. 2013;447(1–2):12–21. - PubMed - DOI
    1. Ita K. Recent progress in transdermal sonophoresis. Pharm Dev Technol. 2017a;22(4):458–66. - PubMed - DOI
    1. Karande P, Mitragotri S. Enhancement of transdermal drug delivery via synergistic action of chemicals. Biochim Biophys Acta. 2009;1788(11):2362–73. - PubMed - DOI
    1. Hadgraft J, Lane ME. Passive transdermal drug delivery systems. Am J Drug Deliv. 2006;4(3):153–60. - DOI

Publication types

Substances

LinkOut - more resources